Searched for
AHMEDABAD PHARMACEUTICAL MANUFACTURING
Sun Pharma secures relief in 'Pantocid' trademark disputeDelhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'P...- India-Japan Summit: Deepening economic ties and strategic investment opportunities for next decadePrime Minister Takaichi's visit to India highlights a robust economic partnership, with Japan a key player in India's infrastructure and au...
- Madhusudan Kela-backed fund buys stake in IPO-bound Steamhouse India for Rs 40 croreAce investor Madhusudan Kela's funds, along with Niveshaay Sambhav Fund, have injected Rs 49.99 crore into Steamhouse India via a pre-IPO p...
- Smaller cities power India’s corporate travel surgeCorporate travel in India is increasingly shifting towards smaller cities, with nearly 60% of bookings now originating from or heading to t...
- EV, FinTech jobs set to deliver biggest raisesIndian employees can anticipate salary increments of 8.6% to 10.2% in FY2026-27, with EV infrastructure, fintech, and healthcare sectors le...
- India Inc to dole out salary hikes of up to 10.2 pc across industries in FY27: ReportCorporate India anticipates salary increments between 8.6% and 10.2% this financial year, driven by demand for skilled talent in high-growt...
- NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedingsThe NCLAT has ruled in favor of Lyka Labs. It overturned a previous NCLT decision. Modi Lifecare Industries must now pay Rs 63 lakh within ...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Odisha CM Majhi on 3-day Gujarat visit to boost investmentsThe outreach focuses on key sectors like textiles, chemicals, metals, and pharmaceuticals, aiming to generate investment intent and sign Mo...
- Amneal Pharmaceuticals to invest up to USD 200 mn in India to set up 2 new plantsAmneal Pharmaceuticals announces a significant investment of up to USD 200 million in India over the next four to five years. The funds wil...
- US drug maker Baxter opens R&D centre in AhmedabadBaxter said the Ahmedabad R&D centre will help the company to accelerate innovation in generic and differentiated injectable pharmaceutical...
- Lincoln Pharma gets Gujarat food & drug regulator nod to manufacture COVID-19 drugsThe approval by the state regulator is to manufacture both the drugs in the strengths of 200 mg, 300 mg and 400 mg, the statement said. Aft...
- Questions on data integrity undermines framework of trust: Richard Johnson, PDAIn all of the activities of PDA worldwide, we work to identify best practices and target continuous improvement in pharmaceutical processes.
- Schott Glass appointed to BIS, to advise on pharma glassSchott Glass has been appointed to India's national standards body. The co will advise on specifications and guidelines for various kinds o...
- USFDA revoke's warning to Cadila HealthcareThe US drug regulator has revoked its earlier warning letter to Ahmedabad-based Cadila Healthcare Ltd.
- HC grants relief to Troikaa in patent case; restrains two firms from selling Dynapar injectionsHC has granted a temporary relief to Troikaa restraining two pharma companies from making & selling the patented versions of diclofenac inj...
- Zydus plans to buy US drug cos for $60 mnZydus Cadila plans to acquire US-based generic pharma company. The Ahmedabad-based firm signed an asset purchase agreement with a US-based ...
- Dishman ties up with California biotech coThe Rs 1,000-crore Dishman Pharmaceuticals, an Ahmedabad-based contract research and manufacturing services (CRAMS) major, has entered into...
- Dishman in pact with US-based CodexisThe Rs 1000-crore Dishman Pharmaceuticals, an Ahmedabad-based Contract Research and Manufacturing Services (CRAMS) major, has entered into ...
Load More
